Taeko Wada

1.4k total citations
21 papers, 1.0k citations indexed

About

Taeko Wada is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Taeko Wada has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Hematology and 4 papers in Oncology. Recurrent topics in Taeko Wada's work include Histone Deacetylase Inhibitors Research (9 papers), Protein Degradation and Inhibitors (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Taeko Wada is often cited by papers focused on Histone Deacetylase Inhibitors Research (9 papers), Protein Degradation and Inhibitors (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Taeko Wada collaborates with scholars based in Japan, Australia and Croatia. Taeko Wada's co-authors include Yusuke Furukawa, Jiro Kikuchi, Yasuhiko Kano, Daisuke Koyama, Tohru Izumi, Rumi Shimizu, R Shimizu, Masaharu Nobuyoshi, K Ozawa and Mitsuo Mita and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Taeko Wada

20 papers receiving 1.0k citations

Peers

Taeko Wada

HEMAT

ONCOL

GENET

IMMUN

Juraj Bies United States

Nabeel R. Yaseen United States

Ranjan Maity Canada

Allen Coleman United States

Ferdinand Kappes Germany

Uta Fuchs Germany

Chiara Ronchini Italy

Alwin Kraemer Germany

Helen Impey Australia

Dennis K. Watson United States

Juraj Bies United States

Taeko Wada

782 ×1.0

274 ×0.9

HEMAT

307 ×1.4

ONCOL

71 ×0.6

GENET

168 ×1.5

IMMUN

Citations per year, relative to Taeko Wada Taeko Wada (= 1×) peers Juraj Bies

Countries citing papers authored by Taeko Wada

Since Specialization

Citations

This map shows the geographic impact of Taeko Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taeko Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taeko Wada more than expected).

Fields of papers citing papers by Taeko Wada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taeko Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taeko Wada. The network helps show where Taeko Wada may publish in the future.

Co-authorship network of co-authors of Taeko Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Taeko Wada. A scholar is included among the top collaborators of Taeko Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taeko Wada. Taeko Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tago, Kenji, Satoshi Ohta, Megumi Funakoshi‐Tago, et al.. (2021). K15 promoter-driven enforced expression of NKIRAS exhibits tumor suppressive activity against the development of DMBA/TPA-induced skin tumors. Scientific Reports. 11(1). 20658–20658.

Takeuchi, Miki, Ryo Abe, Hiroshi Kaneko, et al.. (2020). Splicing- and demethylase-independent functions of LSD1 in zebrafish primitive hematopoiesis. Scientific Reports. 10(1). 8521–8521. 58 indexed citations

Kikuchi, Jiro, Daisuke Koyama, Taeko Wada, et al.. (2015). Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. Experimental Hematology. 43(9). S64–S64. 1 indexed citations

Wada, Taeko, Daisuke Koyama, Jiro Kikuchi, Hiroaki Honda, & Yusuke Furukawa. (2015). Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation. Blood. 125(24). 3731–3746. 43 indexed citations

Hiraoka, Nobuya, Jiro Kikuchi, Takahiro Yamauchi, et al.. (2014). Purine Analog-Like Properties of Bendamustine Underlie Rapid Activation of DNA Damage Response and Synergistic Effects with Pyrimidine Analogues in Lymphoid Malignancies. PLoS ONE. 9(3). e90675–e90675. 21 indexed citations

Koyama, Daisuke, Jiro Kikuchi, Nobuya Hiraoka, et al.. (2013). Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia. Leukemia. 28(6). 1216–1226. 55 indexed citations

Hiraoka, Nobuya, Jiro Kikuchi, Daisuke Koyama, et al.. (2013). Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma. Blood Cancer Journal. 3(12). e169–e169. 15 indexed citations

Kikuchi, Jiro, Satoshi Yamada, Daisuke Koyama, et al.. (2013). The Novel Orally Active Proteasome Inhibitor K-7174 Exerts Anti-myeloma Activity in Vitro and in Vivo by Down-regulating the Expression of Class I Histone Deacetylases. Journal of Biological Chemistry. 288(35). 25593–25602. 24 indexed citations

Kikuchi, Jiro, Naoya Shibayama, Satoshi Yamada, et al.. (2013). Homopiperazine Derivatives as a Novel Class of Proteasome Inhibitors with a Unique Mode of Proteasome Binding. PLoS ONE. 8(4). e60649–e60649. 12 indexed citations

10.

Wada, Taeko, Jiro Kikuchi, & Yusuke Furukawa. (2012). Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8. EMBO Reports. 13(2). 142–149. 66 indexed citations

11.

Mitsunaga, Kanae, Jiro Kikuchi, Taeko Wada, & Yusuke Furukawa. (2011). Latexin regulates the abundance of multiple cellular proteins in hematopoietic stem cells. Journal of Cellular Physiology. 227(3). 1138–1147. 22 indexed citations

12.

Furukawa, Yusuke, Nobuya Hiraoka, Taeko Wada, Jiro Kikuchi, & Yasuhiko Kano. (2011). Mechanisms of action and clinical effectiveness of the newly approved anti-cancer drug bendamustine. Folia Pharmacologica Japonica. 138(1). 26–32. 1 indexed citations

13.

Shimizu, R, Jiro Kikuchi, Taeko Wada, et al.. (2010). HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells. Leukemia. 24(10). 1760–1768. 82 indexed citations

14.

Kikuchi, Jiro, Taeko Wada, Rumi Shimizu, et al.. (2010). Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma. Blood. 116(3). 406–417. 112 indexed citations

15.

Wada, Taeko, Jiro Kikuchi, Noriko Nishimura, et al.. (2009). Expression Levels of Histone Deacetylases Determine the Cell Fate of Hematopoietic Progenitors. Journal of Biological Chemistry. 284(44). 30673–30683. 60 indexed citations

16.

Hatano, Kaoru, Jiro Kikuchi, Masaaki Takatoku, et al.. (2008). Bortezomib Overcomes Cell Adhesion-Mediated Drug Resistance Via Down-Regulation of VLA-4 Expression in Multiple Myeloma.. Blood. 112(11). 1634–1634. 2 indexed citations

17.

Hatano, Kaoru, Jiro Kikuchi, Masaaki Takatoku, et al.. (2008). Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma. Oncogene. 28(2). 231–242. 152 indexed citations

18.

Kikuchi, Jiro, Rumi Shimizu, Taeko Wada, et al.. (2007). E2F-6 Suppresses Growth-Associated Apoptosis of Human Hematopoietic Progenitor Cells by Counteracting Proapoptotic Activity of E2F-1. Stem Cells. 25(10). 2439–2447. 23 indexed citations

19.

Furukawa, Yutaka, Taeko Wada, Miki Nishimura, et al.. (2005). Methylation Silencing of the Apaf-1 Gene in Acute Leukemia. Molecular Cancer Research. 3(6). 325–334. 65 indexed citations

20.

Yamazaki, Yasuo, Hisashi Koike, Yusuke Sugiyama, et al.. (2002). Cloning and characterization of novel snake venom proteins that block smooth muscle contraction. European Journal of Biochemistry. 269(11). 2708–2715. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact